Dr. Jay Cohen, MD

NPI: 1104806603
Total Payments
$474,566
2024 Payments
$104,951
Companies
48
Transactions
894
Medicare Patients
599
Medicare Billing
$38,225

Payment Breakdown by Category

Other$381,170 (80.3%)
Travel$47,791 (10.1%)
Consulting$23,611 (5.0%)
Food & Beverage$21,529 (4.5%)
Research$320.00 (0.1%)
Education$145.70 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $358,489 169 75.5%
Travel and Lodging $47,791 160 10.1%
Consulting Fee $23,611 18 5.0%
Food and Beverage $21,529 525 4.5%
Honoraria $17,400 6 3.7%
Current or prospective ownership or investment interest $5,250 1 1.1%
Unspecified $320.00 3 0.1%
Education $145.70 11 0.0%
Compensation for serving as faculty or as a speaker for a medical education program $31.70 1 0.0%

Payments by Type

General
$474,246
891 transactions
Research
$320.00
2 transactions
Ownership
$0
1 transactions

Top Paying Companies

Company Total Records Latest Year
MAYNE PHARMA COMMERCIAL LLC $119,222 122 $0 (2024)
AbbVie Inc. $84,649 165 $0 (2023)
Myovant Sciences Inc. $61,761 84 $0 (2022)
Sumitomo Pharma America, Inc. $43,867 68 $0 (2024)
PFIZER INC. $34,349 43 $0 (2024)
Bayer Healthcare Pharmaceuticals Inc. $30,655 40 $0 (2024)
Duchesnay USA Incorporated $28,179 52 $0 (2019)
TherapeuticsMD, Inc. $27,480 59 $0 (2022)
Lupin Inc. $8,395 12 $0 (2021)
Renovia Inc $6,708 10 $0 (2020)

Payment History by Year

Year Amount Transactions Top Company
2024 $104,951 113 MAYNE PHARMA COMMERCIAL LLC ($80,062)
2023 $86,998 156 MAYNE PHARMA COMMERCIAL LLC ($39,160)
2022 $81,450 129 Myovant Sciences Inc. ($46,904)
2021 $31,379 88 Myovant Sciences Inc. ($14,857)
2020 $20,641 66 AbbVie Inc. ($14,243)
2019 $91,375 178 AbbVie, Inc. ($62,782)
2018 $38,774 101 Duchesnay USA Incorporated ($22,739)
2017 $18,997 63 Roche Diagnostics Corporation ($5,601)

All Payment Transactions

894 individual payment records from CMS Open Payments — Page 1 of 36

Date Company Product Nature Form Amount Type
12/12/2024 MAYNE PHARMA COMMERCIAL LLC NEXTSTELLIS (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $3,240.00 General
Category: CONTRACEPTIVE
12/12/2024 MAYNE PHARMA COMMERCIAL LLC NEXTSTELLIS (Drug) Food and Beverage In-kind items and services $122.50 General
Category: CONTRACEPTIVE
12/09/2024 PFIZER INC. ABRYSVO (Biological) Food and Beverage In-kind items and services $20.43 General
Category: VACCINES
11/20/2024 MAYNE PHARMA COMMERCIAL LLC Food and Beverage In-kind items and services $10.32 General
11/20/2024 MAYNE PHARMA COMMERCIAL LLC Food and Beverage In-kind items and services $5.73 General
11/15/2024 Astellas Pharma US Inc Veozah (Drug) Food and Beverage In-kind items and services $33.23 General
Category: Biological
11/13/2024 MAYNE PHARMA COMMERCIAL LLC NEXTSTELLIS (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $5,400.00 General
Category: CONTRACEPTIVE
11/13/2024 MAYNE PHARMA COMMERCIAL LLC NEXTSTELLIS (Drug) Travel and Lodging In-kind items and services $575.95 General
Category: CONTRACEPTIVE
11/13/2024 MAYNE PHARMA COMMERCIAL LLC NEXTSTELLIS (Drug) Travel and Lodging In-kind items and services $210.62 General
Category: CONTRACEPTIVE
11/13/2024 MAYNE PHARMA COMMERCIAL LLC NEXTSTELLIS (Drug) Food and Beverage Cash or cash equivalent $135.72 General
Category: CONTRACEPTIVE
11/13/2024 MAYNE PHARMA COMMERCIAL LLC NEXTSTELLIS (Drug) Food and Beverage In-kind items and services $101.03 General
Category: CONTRACEPTIVE
11/11/2024 MAYNE PHARMA COMMERCIAL LLC NEXTSTELLIS (Drug) Food and Beverage Cash or cash equivalent $36.68 General
Category: CONTRACEPTIVE
11/04/2024 Sumitomo Pharma America, Inc. MYFEMBREE (Drug) Food and Beverage In-kind items and services $4.92 General
Category: HORMONE THERAPY
10/31/2024 Sumitomo Pharma America, Inc. MYFEMBREE (Drug) Travel and Lodging Cash or cash equivalent $2,500.00 General
Category: HORMONE THERAPY
10/31/2024 Sumitomo Pharma America, Inc. MYFEMBREE (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,460.00 General
Category: HORMONE THERAPY
10/28/2024 BIOTISSUE HOLDINGS INC. Food and Beverage Cash or cash equivalent $16.58 General
10/28/2024 MAYNE PHARMA COMMERCIAL LLC Food and Beverage In-kind items and services $13.96 General
10/22/2024 MAYNE PHARMA COMMERCIAL LLC ANNOVERA (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $5,400.00 General
Category: CONTRACEPTIVE
10/22/2024 MAYNE PHARMA COMMERCIAL LLC ANNOVERA (Drug) Travel and Lodging In-kind items and services $831.87 General
Category: CONTRACEPTIVE
10/22/2024 MAYNE PHARMA COMMERCIAL LLC ANNOVERA (Drug) Travel and Lodging In-kind items and services $453.94 General
Category: CONTRACEPTIVE
10/22/2024 MAYNE PHARMA COMMERCIAL LLC ANNOVERA (Drug) Food and Beverage In-kind items and services $104.98 General
Category: CONTRACEPTIVE
10/22/2024 MAYNE PHARMA COMMERCIAL LLC ANNOVERA (Drug) Food and Beverage Cash or cash equivalent $68.11 General
Category: CONTRACEPTIVE
10/16/2024 Bayer Healthcare Pharmaceuticals Inc. Kyleena (Drug), Mirena Food and Beverage In-kind items and services $28.22 General
Category: Womens Health
10/15/2024 Evofem Biosciences, Inc. Food and Beverage In-kind items and services $18.00 General
10/02/2024 MAYNE PHARMA COMMERCIAL LLC Food and Beverage In-kind items and services $13.37 General

Research Studies & Clinical Trials

Study Name Company Amount Records
A RANDOMIZED, PLACEBO-CONTROLLED, PARALLEL GROUP, MULTICENTER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ULIPRISTAL ACETATE FOR THE INTERMITTENT TREATMENT OF ABNORMAL UTERINE BLEEDING ASSOCIATED WITH LEIOMYOMAS Allergan Inc. $320.00 2

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 4 177 183 $30,679 $10,994
2022 4 134 140 $24,114 $8,891
2021 5 158 165 $26,518 $10,237
2020 5 130 134 $24,940 $8,104
Total Patients
599
Total Services
622
Medicare Billing
$38,225
Procedure Codes
18

All Medicare Procedures & Services

18 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 52 58 $13,050 $5,274 40.4%
Q0091 Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory Office 2023 60 60 $8,580 $2,623 30.6%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 37 37 $5,661 $1,947 34.4%
G0101 Cervical or vaginal cancer screening; pelvic and clinical breast examination Office 2023 28 28 $3,388 $1,150 33.9%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 48 52 $11,700 $4,710 40.3%
Q0091 Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory Office 2022 41 41 $5,863 $1,844 31.4%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 25 27 $4,131 $1,486 36.0%
G0101 Cervical or vaginal cancer screening; pelvic and clinical breast examination Office 2022 20 20 $2,420 $850.98 35.2%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 27 29 $6,525 $2,914 44.7%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 33 38 $5,814 $2,568 44.2%
Q0091 Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory Office 2021 50 50 $7,150 $2,260 31.6%
G0101 Cervical or vaginal cancer screening; pelvic and clinical breast examination Office 2021 37 37 $4,477 $1,539 34.4%
99203 New patient outpatient visit, total time 30-44 minutes Office 2021 11 11 $2,552 $955.16 37.4%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2020 23 23 $7,843 $2,758 35.2%
Q0091 Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory Office 2020 43 43 $6,149 $1,915 31.1%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 19 20 $4,500 $1,288 28.6%
G0101 Cervical or vaginal cancer screening; pelvic and clinical breast examination Office 2020 28 28 $3,388 $1,206 35.6%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 17 20 $3,060 $935.88 30.6%

About Dr. Jay Cohen, MD

Dr. Jay Cohen, MD is a Obstetrics & Gynecology healthcare provider based in Plantation, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1104806603.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jay Cohen, MD has received a total of $474,566 in payments from pharmaceutical and medical device companies, with $104,951 received in 2024. These payments were reported across 894 transactions from 48 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($358,489).

As a Medicare-enrolled provider, Cohen has provided services to 599 Medicare beneficiaries, totaling 622 services with total Medicare billing of $38,225. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.

Practice Information

  • Specialty Obstetrics & Gynecology
  • Location Plantation, FL
  • Active Since 01/19/2006
  • Last Updated 01/28/2022
  • Taxonomy Code 207V00000X
  • Entity Type Individual
  • NPI Number 1104806603

Products in Payments

  • MYFEMBREE (Drug) $137,983
  • NEXTSTELLIS (Drug) $103,981
  • Orilissa (Drug) $62,894
  • Kerendia (Drug) $30,220
  • Osphena (Drug) $28,159
  • ANNOVERA (Drug) $17,335
  • ORILISSA (Drug) $12,760
  • BIJUVA (Drug) $8,663
  • METHERGINE (Drug) $8,312
  • ORIAHNN (Drug) $6,833
  • leva Pelvic Floor Trainer (Device) $6,684
  • RS Harmony Test Related Products (Device) $5,637
  • IMVEXXY (Drug) $5,265
  • PARAGARD (Drug) $5,160
  • Paragard (Device) $4,144
  • INTRAROSA (Drug) $1,704
  • LO LOESTRIN FE (Drug) $968.71
  • Slynd (Drug) $670.32
  • Kyleena (Drug) $400.96
  • Femring (Drug) $300.00

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Obstetrics & Gynecology Doctors in Plantation